Clinical Trial

The Effects of Some Antihyperglycemic Drugs on Cognitive Function and Risk of Depression of Diabetic Patients

Study acronym: MCI
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to investigate the effects of DPP-4 Is+ metformin versus SGLT2 Is + metformin on the risk of cognitive decline and depression in patients with T2DM.
Protocol Amendment History 2 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-25
notable Primary completion pushed: 2026-06-01 -> 2026-07-01 2026-07-25
Trial Details
NCT Number NCT07244770
Lead Sponsor Beni-Suef University
Conditions MCI
Enrollment 300 participants
Start Date 2025-01-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-24